Plain-English translation of NCT06159335 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a combination of two advanced imaging techniques—PET and MRI scans done on the same machine—can better detect cancer in the brain than standard imaging alone. The study focuses on patients who have brain cancer that has spread from elsewhere, and who have already received radiation therapy and immunotherapy. Researchers hope this new imaging approach will help doctors more accurately tell whether changes they see on scans are from remaining cancer or from the effects of treatment.
After patients receive radiation and immunotherapy for brain cancer, doctors sometimes struggle to figure out whether imaging changes show new or remaining cancer, or whether they're just normal healing responses to treatment. Better imaging tools could help doctors make faster, more accurate decisions about next steps in care.
You likely qualify if…
You likely don't qualify if…
You would come to the research center for one imaging visit lasting 30 to 60 minutes. During this visit, you would receive an injection of a special imaging tracer and then undergo PET and MRI scans on a combined machine that uses a powerful magnet and radioactive tracer to create detailed pictures of your brain. The scans are painless, though you need to remain still during the procedure. If you need a mild anti-anxiety medication to help you stay calm, you can take one you already have a prescription for, but you'll need to arrange a driver to bring you to the visit.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States